CGEM - Viking CRISPR Intellia among potential M&A targets: Wells Fargo
2024-05-25 10:24:03 ET
More on AbbVie, Amgen, etc.
- Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
- Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors
- Amgen Stock: Poised To Break Out (Technical Analysis)
- Bristol-Myers Squibb snaps six days of losses, trades in the green
- Bristol-Myers, Sanofi liability in Hawaii Plavix litigation tops $900M